Machine learning assisted-nanomedicine using magnetic nanoparticles for central nervous system diseases

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Neuroscience

Background:

• Magnetic nanoparticles (MNPs) exhibit unique properties valuable for biomedical applications.
• Their magnetic characteristics enable targeted therapies and diagnostics, particularly for central nervous system (CNS) diseases.
• MNPs are crucial for image-guided therapy and theranostics.

Purpose of the Study:

• To review recent advancements in magnetic nanoparticles for CNS disease applications.
• To explore the integration of machine learning (ML) in nanomedicine development.
• To highlight ML's role in bridging basic and clinical research for nanomaterials.

Main Methods:

• Literature review of magnetic nanoparticle applications in CNS disorders.
• Analysis of machine learning methodologies applied to nanomaterial development.
• Examination of ML's impact across the nanomedicine lifecycle.

Main Results:

• Magnetic nanoparticles show promise for treating Alzheimer's, Parkinson's, epilepsy, multiple sclerosis, and drug addiction.
• Machine learning accelerates nanomaterial processing, optimization, and development.
• ML aids in nanoparticle synthesis, characterization, performance prediction, and disease diagnosis.

Conclusions:

• Magnetic nanoparticles are highly beneficial for CNS disease therapy and diagnostics.
• Machine learning is a powerful tool for advancing nanomedicine research and clinical translation.
• The synergy of MNPs and ML holds significant potential for personalized CNS treatments.